Vitrisa Therapeutics
Get Full AccessDescription
- Vitrisa Therapeutics is a privately held, preclinical stage, biotech company headquartered in the San Francisco Bay Area. The company is focused on a proprietary suite of technologies that the discovery & development of optimized ocular therapeutics with the potential to address the underlying mechanisms of vision loss in a wide range of ocular diseases. Our goal is to bring therapeutics that preserve or restore vision to people suffering from sight threatening ocular diseases - with an initial emphasis on orphan and rare pediatric ocular indications.
-
Headquarters:700 Larkspur Landing Circle , Larkspur, California, United States
More -
Phone Number:
-
Website: https://www.vitrisatherapeutics.com
-
Employees:16
-
Revenue:$10 - 50M
-
Legal Name:Vitrisa Therapeutics
-
Vitrisa Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Vitrisa Therapeutics
-
Where are Vitrisa Therapeutics's Headquarters?
Vitrisa Therapeutics's Headquarters are in 700 Larkspur Landing Circle ,Larkspur,California,United States
-
What is Vitrisa Therapeutics's official website?
Vitrisa Therapeutics's official website is https://www.vitrisatherapeutics.com
-
What is Vitrisa Therapeutics's Revenue?
Vitrisa Therapeutics's revenue is $10 - 50M
-
What is Vitrisa Therapeutics's NAICS code?
Vitrisa Therapeutics's NAICS code is 541713
-
How many employees are working in Vitrisa Therapeutics
Vitrisa Therapeutics has 16 employees
-
What is Vitrisa Therapeutics's Industry?
Vitrisa Therapeutics is in the industry of Biotechnology
-
Who is Vitrisa Therapeutics's Program Manager?
Vitrisa Therapeutics's Program Manager is Catherine Fletcher